Ocular Therapeutix Announces Positive Topline Phase 1 Data for AXPAXLI in Diabetic Retinopathy

18.04.2024 - 46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0% in the control arm No patients in the AXPAXLI group experienced worsening in DRSS compared to ... Seite 1

Related Keywords

Jeffreys Heier , ,Nasdaq ,Ocular Therapeutix Inc ,Topline Phase ,Diabetic Retinopathy Severity Scale ,Chief Scientific Officer ,